Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peritoneal Neoplasms | 24 | 2023 | 710 | 9.960 |
Why?
|
Rectal Neoplasms | 15 | 2024 | 1156 | 4.440 |
Why?
|
Interdisciplinary Communication | 9 | 2020 | 928 | 4.130 |
Why?
|
Appendiceal Neoplasms | 9 | 2023 | 155 | 3.980 |
Why?
|
Practice Guidelines as Topic | 19 | 2020 | 7400 | 3.720 |
Why?
|
Chicago | 18 | 2020 | 254 | 2.990 |
Why?
|
Physicians, Women | 9 | 2022 | 510 | 2.830 |
Why?
|
Colorectal Neoplasms | 16 | 2024 | 6919 | 2.340 |
Why?
|
Physicians | 12 | 2024 | 4583 | 2.250 |
Why?
|
Hyperthermia, Induced | 4 | 2022 | 417 | 2.220 |
Why?
|
Colorectal Surgery | 6 | 2020 | 122 | 2.140 |
Why?
|
Neuroendocrine Tumors | 5 | 2020 | 641 | 2.110 |
Why?
|
Anus Neoplasms | 6 | 2024 | 329 | 1.970 |
Why?
|
Appendectomy | 7 | 2020 | 433 | 1.930 |
Why?
|
Ukraine | 11 | 2024 | 149 | 1.930 |
Why?
|
Consensus | 18 | 2020 | 3133 | 1.570 |
Why?
|
Job Satisfaction | 4 | 2019 | 545 | 1.490 |
Why?
|
Desmoplastic Small Round Cell Tumor | 2 | 2020 | 33 | 1.380 |
Why?
|
Mesothelioma | 3 | 2021 | 807 | 1.370 |
Why?
|
Professional Autonomy | 2 | 2020 | 171 | 1.270 |
Why?
|
Abdomen | 3 | 2019 | 1128 | 1.260 |
Why?
|
Perineum | 3 | 2024 | 208 | 1.230 |
Why?
|
Appendicitis | 3 | 2019 | 675 | 1.210 |
Why?
|
Neoplasm Staging | 15 | 2023 | 11118 | 1.160 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2021 | 517 | 1.120 |
Why?
|
Treatment Refusal | 2 | 2020 | 429 | 1.090 |
Why?
|
Congresses as Topic | 3 | 2020 | 803 | 1.050 |
Why?
|
Digestive System Surgical Procedures | 4 | 2020 | 571 | 1.040 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2020 | 617 | 0.910 |
Why?
|
Survival Rate | 15 | 2022 | 12727 | 0.900 |
Why?
|
Leadership | 3 | 2022 | 1386 | 0.890 |
Why?
|
Early Detection of Cancer | 4 | 2024 | 3196 | 0.890 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2528 | 0.870 |
Why?
|
Laparoscopy | 3 | 2019 | 2030 | 0.850 |
Why?
|
Adenocarcinoma | 7 | 2023 | 6340 | 0.800 |
Why?
|
Career Choice | 2 | 2019 | 757 | 0.780 |
Why?
|
Colectomy | 4 | 2020 | 686 | 0.780 |
Why?
|
Stomach Neoplasms | 3 | 2023 | 1458 | 0.780 |
Why?
|
Peritoneal Diseases | 1 | 2022 | 75 | 0.770 |
Why?
|
Databases, Factual | 9 | 2021 | 7969 | 0.750 |
Why?
|
Healthcare Disparities | 4 | 2020 | 3352 | 0.730 |
Why?
|
Rectum | 4 | 2023 | 891 | 0.720 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11732 | 0.710 |
Why?
|
Humans | 113 | 2024 | 761098 | 0.690 |
Why?
|
Breast Feeding | 2 | 2018 | 1355 | 0.680 |
Why?
|
Duodenal Neoplasms | 1 | 2020 | 114 | 0.680 |
Why?
|
Mothers | 3 | 2019 | 2193 | 0.680 |
Why?
|
Ileum | 2 | 2020 | 557 | 0.670 |
Why?
|
Parental Leave | 2 | 2017 | 92 | 0.670 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.650 |
Why?
|
Postoperative Complications | 8 | 2024 | 15634 | 0.650 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 151 | 0.640 |
Why?
|
Prescriptions | 2 | 2020 | 386 | 0.630 |
Why?
|
Fecal Impaction | 1 | 2018 | 32 | 0.620 |
Why?
|
Omentum | 1 | 2019 | 167 | 0.610 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 113 | 0.610 |
Why?
|
Career Mobility | 1 | 2020 | 259 | 0.610 |
Why?
|
Health Status Disparities | 2 | 2020 | 1846 | 0.610 |
Why?
|
Goals | 1 | 2023 | 708 | 0.600 |
Why?
|
Ascites | 1 | 2020 | 338 | 0.600 |
Why?
|
Faculty, Medical | 3 | 2022 | 1205 | 0.600 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2021 | 4021 | 0.600 |
Why?
|
Carcinoid Tumor | 1 | 2019 | 224 | 0.590 |
Why?
|
Lymph Nodes | 3 | 2020 | 3461 | 0.590 |
Why?
|
Physicians, Primary Care | 1 | 2024 | 618 | 0.580 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 314 | 0.570 |
Why?
|
Abdominal Abscess | 1 | 2018 | 153 | 0.570 |
Why?
|
Anal Canal | 2 | 2020 | 374 | 0.560 |
Why?
|
Crohn Disease | 3 | 2020 | 2279 | 0.560 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2019 | 219 | 0.560 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2020 | 3512 | 0.560 |
Why?
|
Databases as Topic | 1 | 2019 | 473 | 0.550 |
Why?
|
Palliative Care | 4 | 2021 | 3593 | 0.550 |
Why?
|
Colonic Diseases | 1 | 2018 | 201 | 0.540 |
Why?
|
Qualitative Research | 3 | 2024 | 3016 | 0.540 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.540 |
Why?
|
Female | 63 | 2024 | 392458 | 0.540 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 422 | 0.530 |
Why?
|
Intestinal Obstruction | 1 | 2020 | 432 | 0.530 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2020 | 955 | 0.500 |
Why?
|
Societies, Medical | 4 | 2020 | 3923 | 0.500 |
Why?
|
United States | 29 | 2023 | 72337 | 0.490 |
Why?
|
Internship and Residency | 4 | 2024 | 5879 | 0.490 |
Why?
|
Medicaid | 5 | 2023 | 2814 | 0.480 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 339 | 0.480 |
Why?
|
Retrospective Studies | 28 | 2024 | 80673 | 0.480 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4308 | 0.480 |
Why?
|
Academic Medical Centers | 2 | 2022 | 2757 | 0.470 |
Why?
|
Propensity Score | 2 | 2020 | 1913 | 0.470 |
Why?
|
Patient Protection and Affordable Care Act | 5 | 2023 | 1187 | 0.470 |
Why?
|
Combined Modality Therapy | 7 | 2022 | 8519 | 0.470 |
Why?
|
Colonic Polyps | 1 | 2019 | 553 | 0.470 |
Why?
|
Colon | 2 | 2020 | 1791 | 0.460 |
Why?
|
Surgical Flaps | 3 | 2024 | 1670 | 0.460 |
Why?
|
Middle Aged | 40 | 2024 | 220835 | 0.460 |
Why?
|
Necrosis | 1 | 2018 | 1611 | 0.450 |
Why?
|
General Surgery | 2 | 2024 | 1692 | 0.430 |
Why?
|
Ovarian Neoplasms | 2 | 2020 | 4853 | 0.430 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9278 | 0.430 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1530 | 0.410 |
Why?
|
Male | 48 | 2024 | 360675 | 0.410 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2017 | 497 | 0.410 |
Why?
|
Occult Blood | 2 | 2024 | 197 | 0.410 |
Why?
|
Medicine | 2 | 2017 | 942 | 0.400 |
Why?
|
Pain, Postoperative | 3 | 2020 | 1738 | 0.380 |
Why?
|
Lymphoma | 1 | 2020 | 1898 | 0.370 |
Why?
|
Anastomosis, Surgical | 3 | 2019 | 982 | 0.350 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3808 | 0.340 |
Why?
|
Pregnancy Outcome | 2 | 2017 | 2920 | 0.330 |
Why?
|
Hospitals, Community | 2 | 2021 | 365 | 0.310 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2000 | 0.310 |
Why?
|
Neoplasms | 6 | 2024 | 22125 | 0.310 |
Why?
|
Carcinoma | 1 | 2019 | 2328 | 0.300 |
Why?
|
Heart-Assist Devices | 1 | 2019 | 1288 | 0.300 |
Why?
|
Quality Improvement | 2 | 2024 | 3801 | 0.290 |
Why?
|
Mentors | 2 | 2024 | 663 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4340 | 0.290 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1923 | 0.280 |
Why?
|
Adult | 26 | 2024 | 221083 | 0.270 |
Why?
|
Prognosis | 9 | 2022 | 29672 | 0.270 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7804 | 0.270 |
Why?
|
Colonoscopy | 3 | 2024 | 1398 | 0.270 |
Why?
|
Health Services Accessibility | 4 | 2023 | 5427 | 0.270 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39121 | 0.260 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2372 | 0.260 |
Why?
|
Incidence | 7 | 2021 | 21357 | 0.250 |
Why?
|
Awards and Prizes | 2 | 2020 | 362 | 0.250 |
Why?
|
Aged | 21 | 2023 | 169266 | 0.250 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3882 | 0.250 |
Why?
|
Specialties, Surgical | 2 | 2020 | 389 | 0.250 |
Why?
|
Treatment Outcome | 11 | 2020 | 64670 | 0.240 |
Why?
|
Hysterectomy | 2 | 2020 | 856 | 0.240 |
Why?
|
Sepsis | 1 | 2018 | 2586 | 0.240 |
Why?
|
Breast Neoplasms | 4 | 2020 | 20981 | 0.240 |
Why?
|
Intestine, Small | 2 | 2020 | 1207 | 0.220 |
Why?
|
Minority Groups | 3 | 2020 | 1201 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2948 | 0.210 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3591 | 0.210 |
Why?
|
Survival Analysis | 3 | 2020 | 10083 | 0.200 |
Why?
|
Remote Consultation | 1 | 2024 | 237 | 0.200 |
Why?
|
Prostatectomy | 2 | 2020 | 1825 | 0.190 |
Why?
|
Tourniquets | 1 | 2022 | 107 | 0.190 |
Why?
|
Pseudomyxoma Peritonei | 1 | 2021 | 21 | 0.190 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12467 | 0.180 |
Why?
|
United States Department of Defense | 1 | 2020 | 34 | 0.180 |
Why?
|
Aged, 80 and over | 7 | 2020 | 58946 | 0.180 |
Why?
|
Fissure in Ano | 1 | 2020 | 14 | 0.180 |
Why?
|
Melanoma | 1 | 2018 | 5694 | 0.170 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2019 | 15 | 0.170 |
Why?
|
Online Systems | 1 | 2020 | 182 | 0.160 |
Why?
|
Interviews as Topic | 2 | 2024 | 2696 | 0.160 |
Why?
|
Mitomycin | 1 | 2019 | 263 | 0.160 |
Why?
|
Abdominal Muscles | 1 | 2019 | 169 | 0.160 |
Why?
|
Age Factors | 3 | 2020 | 18385 | 0.160 |
Why?
|
Mass Screening | 3 | 2024 | 5425 | 0.160 |
Why?
|
Peritoneal Lavage | 1 | 2018 | 30 | 0.160 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 247 | 0.160 |
Why?
|
Monophenol Monooxygenase | 1 | 2008 | 72 | 0.160 |
Why?
|
Absenteeism | 1 | 2020 | 247 | 0.160 |
Why?
|
Nutritional Support | 1 | 2020 | 173 | 0.150 |
Why?
|
Insurance, Health | 2 | 2020 | 2494 | 0.150 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 212 | 0.150 |
Why?
|
Hepatectomy | 1 | 2021 | 557 | 0.150 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2019 | 209 | 0.150 |
Why?
|
Ileostomy | 1 | 2018 | 121 | 0.140 |
Why?
|
Professional Competence | 1 | 2020 | 430 | 0.140 |
Why?
|
Patient Care | 1 | 2023 | 622 | 0.140 |
Why?
|
Hernia, Inguinal | 1 | 2020 | 220 | 0.140 |
Why?
|
Length of Stay | 3 | 2019 | 6420 | 0.140 |
Why?
|
Workplace | 2 | 2020 | 864 | 0.140 |
Why?
|
Canada | 2 | 2019 | 2125 | 0.140 |
Why?
|
Proctocolectomy, Restorative | 1 | 2019 | 190 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 503 | 0.140 |
Why?
|
Rectus Abdominis | 1 | 2007 | 103 | 0.140 |
Why?
|
Skin Pigmentation | 1 | 2008 | 277 | 0.130 |
Why?
|
Bupivacaine | 1 | 2019 | 411 | 0.130 |
Why?
|
Skull Neoplasms | 1 | 2007 | 173 | 0.130 |
Why?
|
Patient Preference | 1 | 2023 | 926 | 0.130 |
Why?
|
Laparotomy | 1 | 2018 | 456 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 677 | 0.130 |
Why?
|
Insurance Coverage | 3 | 2023 | 1937 | 0.120 |
Why?
|
Markov Chains | 1 | 2019 | 965 | 0.120 |
Why?
|
Logistic Models | 3 | 2020 | 13254 | 0.120 |
Why?
|
Nausea | 1 | 2018 | 679 | 0.120 |
Why?
|
Military Personnel | 1 | 2024 | 1246 | 0.120 |
Why?
|
Melanocytes | 1 | 2008 | 509 | 0.120 |
Why?
|
Vomiting | 1 | 2018 | 651 | 0.120 |
Why?
|
Patient Readmission | 2 | 2019 | 3268 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26068 | 0.120 |
Why?
|
Prospective Studies | 4 | 2019 | 54419 | 0.120 |
Why?
|
Rectal Diseases | 1 | 2016 | 142 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2018 | 578 | 0.120 |
Why?
|
Dilatation | 1 | 2016 | 307 | 0.120 |
Why?
|
Maternal Age | 1 | 2017 | 809 | 0.110 |
Why?
|
Efficiency | 1 | 2017 | 476 | 0.110 |
Why?
|
Postoperative Period | 1 | 2019 | 1818 | 0.110 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2827 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 898 | 0.110 |
Why?
|
Age Distribution | 1 | 2019 | 2873 | 0.110 |
Why?
|
Workload | 1 | 2019 | 844 | 0.110 |
Why?
|
Nerve Block | 1 | 2020 | 705 | 0.110 |
Why?
|
Quinolines | 1 | 2008 | 764 | 0.110 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1723 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1071 | 0.100 |
Why?
|
Sex Factors | 3 | 2020 | 10552 | 0.100 |
Why?
|
Poverty | 2 | 2023 | 2692 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2019 | 703 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3422 | 0.090 |
Why?
|
Hospitals | 2 | 2020 | 3881 | 0.080 |
Why?
|
Curriculum | 2 | 2024 | 3739 | 0.080 |
Why?
|
Motivation | 1 | 2019 | 2003 | 0.080 |
Why?
|
Pregnancy | 3 | 2022 | 29872 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 39953 | 0.080 |
Why?
|
Cohort Studies | 3 | 2021 | 41486 | 0.080 |
Why?
|
Recurrence | 2 | 2019 | 8456 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5249 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6482 | 0.080 |
Why?
|
Income | 1 | 2017 | 1868 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4908 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1923 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4304 | 0.070 |
Why?
|
Primary Health Care | 1 | 2024 | 4673 | 0.070 |
Why?
|
Social Support | 1 | 2017 | 2175 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3238 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1868 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3535 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12058 | 0.060 |
Why?
|
Self Report | 1 | 2017 | 3728 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3925 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Computer Simulation | 1 | 2019 | 6225 | 0.060 |
Why?
|
Risk Factors | 4 | 2020 | 74219 | 0.060 |
Why?
|
Medicare | 2 | 2020 | 6775 | 0.060 |
Why?
|
Traumatology | 1 | 2024 | 100 | 0.060 |
Why?
|
Young Adult | 5 | 2020 | 59199 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4642 | 0.050 |
Why?
|
Committee Membership | 1 | 2020 | 17 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2018 | 26187 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.050 |
Why?
|
Sex Ratio | 1 | 2020 | 107 | 0.040 |
Why?
|
Adolescent | 4 | 2020 | 88271 | 0.040 |
Why?
|
Pelvis | 1 | 2024 | 734 | 0.040 |
Why?
|
Depression, Chemical | 1 | 2008 | 184 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 235 | 0.040 |
Why?
|
Biology | 1 | 2020 | 289 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1743 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2008 | 289 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 956 | 0.040 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2007 | 56 | 0.040 |
Why?
|
Health Expenditures | 2 | 2020 | 2363 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13362 | 0.030 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2021 | 487 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20600 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 821 | 0.030 |
Why?
|
Melanins | 1 | 2008 | 289 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2008 | 411 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 841 | 0.030 |
Why?
|
Hemorrhoids | 1 | 2016 | 19 | 0.030 |
Why?
|
Infant | 1 | 2018 | 36164 | 0.030 |
Why?
|
Liposomes | 1 | 2019 | 783 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
Anus Diseases | 1 | 2016 | 54 | 0.030 |
Why?
|
Morphine | 1 | 2019 | 656 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2020 | 835 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2020 | 2927 | 0.030 |
Why?
|
Patients | 1 | 2020 | 906 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 912 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2008 | 3060 | 0.030 |
Why?
|
Protein Transport | 1 | 2008 | 1959 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2019 | 1264 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1097 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2570 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2024 | 2492 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2007 | 896 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3763 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3550 | 0.020 |
Why?
|
Cell Survival | 1 | 2008 | 5776 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9648 | 0.020 |
Why?
|
Mammography | 1 | 2019 | 2430 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 3696 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3094 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7574 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4319 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8529 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9317 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16947 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10203 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1921 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15308 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4786 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 18926 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10758 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 11103 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13382 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36418 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81324 | 0.010 |
Why?
|
Animals | 1 | 2008 | 168083 | 0.000 |
Why?
|
Concepts
(299)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(76)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_